Clinical Trial Update: S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating docetaxel and cetuximab with radiation therapy in stage III non-small cell lung cancer was terminated, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Lung Cancer | Phase 1 | Status: TERMINATED | Results posted: 2012-12-25